From: Analysis of risk factors of bladder neck contracture following transurethral surgery of prostate
All patients | Cohort | |||||
---|---|---|---|---|---|---|
Resection group (N = 135) | Enucleation group (N = 51) | P value | Resection group (N = 49) | Enucleation group (N = 49) | P value | |
Age (years) | 68.8 ± 10.3 | 72.9 ± 7.4 | 0.049* | 71.6 ± 8.1 | 72.5 ± 7.2 | 0.44 |
Prostate volume (ml) | 51.02 ± 20.72 | 56.37 ± 19.90 | 0.72 | 57.40 ± 23.59 | 54.90 ± 18.87 | 0.42 |
PSA (ng/ml) | 8.77 ± 15.22 | 8.47 ± 13.51 | 0.57 | 8.08 ± 7.90 | 7.88 ± 13.4 | 0.88 |
Maximal urinary flow (ml/sec) | 9.44 ± 7.33 | 8.47 ± 13.51 | 0.58 | 8.46 ± 5.83 | 8.10 ± 6.41 | 0.79 |
Post-voiding residual urine (ml) | 129.28 ± 171.40 | 119.94 ± 167.55 | 0.45 | 124.20 ± 156.88 | 119.88 ± 170.97 | 0.20 |
Foley insertion before TURP or ThuP (yes/no) | 26/109 | 10/41 | 0.96 | 9/40 | 9/40 | 1.0 |
Pre-operation hemoglobin (ng/ml) | 14.06 ± 1.43 | 13.99 ± 1.11 | 0.12 | 14.06 ± 1.60 | 14.02 ± 1.11 | 0.49 |
Post-operation Hemoglobin (ng/ml) | 13.41 ± 1.47 | 13.29 ± 1.08 | 0.01* | 13.28 ± 1.68 | 13.31 ± 1.07 | 0.86 |
Hemoglobin change (ng/ml) | 0.66 ± 0.64 | 0.68 ± 0.71 | 0.82 | 0.77 ± 0.74 | 0.69 ± 0.72 | 0.13 |
Prostate resection weight (g) | 14.64 ± 11.69 | 16.10 ± 15.10 | 0.045* | 17.81 ± 13.65 | 15.33 ± 14.33 | 0.14 |
Percentage of prostate resected (%) | 27.77 ± 14.93 | 26.65 ± 20.57 | 0.015* | 30.10 ± 14.75 | 26.21 ± 20.45 | 0.71 |
Surgical time (min) | 95.71 ± 32.76 | 111.69 ± 35.43 | 0.49 | 102.67 ± 29.92 | 110.33 ± 35.47 | 0.75 |
Hospital stay (days) | 3.13 ± 0.50 | 3.14 ± 0.49 | 0.31 | 3.06 ± 0.48 | 3.14 ± 0.50 | 0.80 |
Smoking (yes/no) | 48/87 | 10/41 | 0.036* | 15/34 | 10/39 | 0.33 |
Hypertension (yes/no) | 65/70 | 26/25 | 0.73 | 25/24 | 24/25 | 1.0 |
Diabetes mellitus (yes/no) | 25/110 | 7/44 | 0.44 | 9/40 | 7/42 | 0.79 |
Cerebrovascular accidents (yes/no) | 12/123 | 6/45 | 0.55 | 5/44 | 5/44 | 1.0 |
Coronary artery disease (yes/no) | 22/113 | 9/42 | 0.83 | 10/39 | 8/41 | 0.82 |
Chronic kidney disease (yes/no) | 16/119 | 9/42 | 0.30 | 8/41 | 8/41 | 1.0 |
Number of comorbidities (≥ 2/ ≤ 1) | 38/97 | 18/33 | 0.34 | 15/34 | 16/33 | 1.0 |
Prostate cancer (yes/no) | 15/120 | 3/48 | 0.28 | 5/44 | 3/46 | 0.73 |
Other malignancy (yes/no) | 9/126 | 1/50 | 0.20 | 3/46 | 1/48 | 0.63 |
Concurrent ESCL (yes/no) | 9/126 | 1/50 | 0.20 | 3/46 | 1/48 | 0.63 |
Recatherization after surgery (yes/no) | 4/131 | 5/46 | 0.052 | 1/48 | 5/44 | 0.22 |
Postopertive urinary tract infection (yes/no) | 3/132 | 1/50 | 0.91 | 1/48 | 1/48 | 1 |
BNC (yes/no) | 45/90 | 17/34 | 1 | 13/36 | 16/33 | 0.69 |